---
title: "Case Study: AWS"
---

[Skip to content](https://letsrenew.co/case-study-aws#main-content)

![Group 37@2x](https://letsrenew.co/hs-fs/hubfs/Group%2037@2x.png?width=191&height=40&name=Group%2037@2x.png)Homepage

- [Home](https://letsrenew.co?hsLang=en)
- [About Us](https://letsrenew.co/home-final-0?hsLang=en)
- [Case Studies](https://letsrenew.co/case-studies?hsLang=en)
- [Services](https://letsrenew.co/home-final-0-0?hsLang=en)

[Get in touch](https://letsrenew.co/contact-us?hsLang=en)

- [Home](https://letsrenew.co?hsLang=en)
- [About Us](https://letsrenew.co/home-final-0?hsLang=en)
- [Case Studies](https://letsrenew.co/case-studies?hsLang=en)
- [Services](https://letsrenew.co/home-final-0-0?hsLang=en)

[Get in touch](https://letsrenew.co/contact-us?hsLang=en)

![aws 2](https://letsrenew.co/hs-fs/hubfs/aws%202.png?width=131&height=119&name=aws%202.png "aws 2")

# Increasing Diversity In Clinical Trials through Synthetic Data

![AWS img (1)](https://letsrenew.co/hs-fs/hubfs/AWS%20img%20(1).png?width=1925&height=2000&name=AWS%20img%20(1).png "AWS img (1)")

## Background

Desire to explore the use of synthetic data in biopharma to unlock new markets and bring this groundbreaking technology to address challenges such as cost and timescale of clinical trials; drug discovery and diversity of patient selection for clinical trials.

## Solution

Demonstrator for Synthetic data to highlight how the technology could address diversity and at risk patient issue via Generative Adversarial Networks and simulation.

Focused on education of Clinical Operations professionals and Chief Medical and Scientific officers of target organisations.

## Outcome

Trialled with Chief Medical Officers increasing uptake of the technology.

## Start Unlocking AI-Driven Growth Today

Unlock the potential of AI and technology to drive your business forward.

[Get in touch](https://letsrenew.co/contact-us?hsLang=en)

![Group 37@2x](https://letsrenew.co/hs-fs/hubfs/Group%2037@2x.png?width=152&height=32&name=Group%2037@2x.png "Group 37@2x")

© 2025 Renew. All rights reserved.

[About Us](https://renew-capital-143422341.hubspotpagebuilder.eu/home-final-0?hsLang=en)   [Services](https://renew-capital-143422341.hubspotpagebuilder.eu/home-final-0-0?hsLang=en)   [Contact](https://renew-capital-143422341.hubspotpagebuilder.eu/contact-us?hsLang=en)

Privacy Policy · Legal · © 2025. All rights reserved.